Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

May 15, 2023

Conditions
Cardiac Arrhythmia
Interventions
DEVICE

Arrhythmia Management System (AMS)

Retrospective collection of data related to subjects who participated in the MAPS 90D0234 study and had a medication change reported will wearing the AMS device.

Trial Locations (8)

25702

St. Mary's Medical Center EP, Huntington

32086

First Coast Heart & Vascular Center, Saint Augustine

34471

Cardiovascular Institute of Central Florida, Ocala

39216

Jackson Heart Clinic, Jackson

75071

CardioVoyage, McKinney

77339

Texas Cardiology Associates of Houston, Kingwood

79109

PharmaTex Research, Amarillo

98166

Dr. Daniel W. Gottlieb, Burien

All Listed Sponsors
lead

Zoll Medical Corporation

INDUSTRY